[1] |
LI Shan, LIU Yixin, REN Feifei, LI Xiangchen, ZHANG Zhiqing.
Research progress of natural plant active ingredients in reversing tumor multidrug resistance by down-regulating P-gp
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 331-340.
|
[2] |
MENG Qiang, LIU Kexin.
Research status and prospect of transporter-mediated drug-drug interactions
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(8): 876-888.
|
[3] |
JIN Le, JIANG Duochen, CHEN Hongxiao, LIU Su, CHEN Zhaolin, JU Jing.
Quercetin reverses adriamycin resistance by activating GSK-3β/β-catenin pathways through GAS5 in breast cancer cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(12): 1344-1351.
|
[4] |
PAN Zhanhe, WANG Xin, SU An, ZHANG Peng, JI Haonan, WANG Xiaomei.
Mechanism of celecoxib reverses adriamycin resistance in NK/T cell lymphoma cells by Notch 1/NF-κB/STAT3 pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(12): 1330-1336.
|
[5] |
LI Xu, Dai Yi, HUANG Jiafeng, WEN Chunjie, ZOU Zhen, Wu Lanxiang, WANG Guo, ZHOU Honghao.
Curcumin increases MDR1 expression in breast cancer MCF-7 and MCF-7/DOX cells through regulating histone acetylation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(5): 512-517.
|
[6] |
WANG Zi-yuan, CHENG Zhuo-an, YIN Pei-hao.
Research advance in resveratrol's inhibition action on multidrug resistance
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(6): 717-720.
|
[7] |
LI Jun, JIANG Kui, ZHANG Xue-mei.
Adervances in the research of multidrug resistance-associated protein 1 and its relationship with tumor
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(3): 351-355.
|
[8] |
WANG Pei-pei, XU Du-juan, HUANG Can, XU Wen-ke, LUAN Jia-jie.
Reversal of human hepatic cancer multidrug resistance is induced by AstragalosideⅡ in BEL-7402/FU cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(2): 139-144.
|
[9] |
LUO Dan, ZHANG Jing-wei, ZHOU Fang, WU Xiao-lan, WANG Guang-ji.
Research progress on the PK evaluation of anti-cancer nano-preparation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(2): 205-211.
|
[10] |
SHEN Qun-shan, HUANG Hou-bao, PAN Cai-ming, XUE Jun, CAI Zhang-yu, WANG Xiao, JIANG Shu-chuan.
Prevention effect of 4-HPR on bladder tumor in SD rats: An in vivo experiment
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(9): 972-977.
|
[11] |
ZHAO Qi-jin, ZHA Wei-bin, ZHOU Fang, WU Xiao-lan, CAO Bei, ZHANG Jing-wei, WANG Guang-ji.
The transcriptional regulation of drug enzymes and transporters mediated by Pregnane X receptor and its significant role in multidrug resistance
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(8): 931-939.
|
[12] |
YANG Yan-lang1,2, ZOU He-qun1, ZHANG Dao-you2, WANG Yu-wei2, LI Fan-xia2, GAO Chao-qing2, XU Hai-hong2, CHENG Xiao-mei2.
Renal tubular protection effect of combining benazepril and spironolactone in adriamycin-induced nephritic rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(4): 381-386.
|
[13] |
CAI Ke, ZHOU Rui, SHI Bai-ling.
Effect of Oct-4 on chemosensitivity of cisplatin against gastric cancer cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(3): 251-255.
|
[14] |
ZHAO Wen-ying, CHEN Dong-yun, XING Wen, WU Ming , YANG Zhi-min, JI Zhao-ning.
Primary exploration on the protective effect of phosphocreatine sodium on adriamycin-induced cardiotoxicity in mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(3): 259-262.
|
[15] |
CHEN Ji-hong, ZHOU Dong, GAO Kun, HE Wei-ming,WANG Yue-juan, SUN Wei.
Expression of NF-κB and IκB in rats with adriamycin nephropathy and the role of Dahuangzhechong Wan
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(1): 22-26.
|